HEALTHY EXTRACTS INC.
No SEC Form 4 filings for $HYEX in the last 30 days.
Healthy Extracts Inc. (OTCQB:HYEX) said it expects Q2 2026 net revenue to exceed $2.0 million, up more than 112% sequentially and 129% year over year. For the first half ended June 30, 2026, it expects net revenue above $3.6 million, up over 93% from H1 2025, citing the Gummy USA merger and the Imaraïs Beauty acquisition.
HEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 hyex_ex10z1.htm SECURITIES PURCHASE AGREEMENT DATED JULY 17, 2026 Securities Purchase Agreement (Fire-Ubiquity) (00346656-5).DOCX SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 17, 2026, by and between Healthy Extrac
HEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. HEALTHY EXTRACTS INC. - Form 8-K SEC filing 0001630176 false 0001630176 2026-07-07 2026-07-07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Dat
Over the past 7 days, alphai's AI scored 1 news story mentioning HYEX (HEALTHY EXTRACTS INC.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent HYEX coverage spans corporate actions and financial news.
The article is a company-specific revenue outlook update tied to recent M&A and a large initial Imaraïs order, which can shift near-term expectations for HYEX’s growth trajectory.
The filing discloses a new convertible note financing, which can be dilutive and may pressure the stock depending on conversion terms and discount.
Board and management change creates near-term uncertainty around brand strategy and internal execution, but no financial guidance or operational metrics were provided.
Board/officer turnover creates near-term execution and governance uncertainty, with potential operational disruption until replacements are named.
alphai scores every news story that mentions HYEX with an AI model for sentiment and relevance, and aggregates insider trades from HEALTHY EXTRACTS INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Healthy Extracts Inc. (OTCQB:HYEX) said it expects Q2 2026 net revenue to exceed $2.0 million, up more than 112% sequentially and 129% year over year. For the first half ended June 30, 2026, it expects net revenue above $3.6 million, up over 93% from H1 2025, citing the Gummy USA merger and the Imaraïs Beauty acquisition.
4 min readHEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 hyex_ex10z1.htm SECURITIES PURCHASE AGREEMENT DATED JULY 17, 2026 Securities Purchase Agreement (Fire-Ubiquity) (00346656-5).DOCX SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 17, 2026, by and between Healthy Extrac
6 min readHEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. HEALTHY EXTRACTS INC. - Form 8-K SEC filing 0001630176 false 0001630176 2026-07-07 2026-07-07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Dat
2 min readHEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. HEALTHY EXTRACTS INC. - Form 8-K SEC filing 0001630176 false 0001630176 2026-07-01 2026-07-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Dat
2 min read